Holen Sie sich die Stockscreener-App
13.86
4.22%
-0.5755
Eyepoint Inc Aktie (EYPT) Neueste Nachrichten
Here’s Why EyePoint, Inc. (EYPT) Is Among the Best Get Rich Quick Stocks - Insider Monkey
Price to sales forward of EyePoint, Inc. – DUS:PV3B - TradingView
Guggenheim reiterates Buy on EyePoint stock, cites trial progress - Investing.com
EyePoint Pharmaceuticals outlines long-term retina strategy as a specialty biotech - AD HOC NEWS
EYPTEyePoint Inc Forecast, Target Price - Finviz
EyePoint CMO Ramiro Ribeiro sells $73,166 in company stock - Investing.com
Form 4 Eyepoint Pharmaceuticals Inc For: 2 July By Investing.com - Investing.com Canada
EyePoint CMO sells 4,875 shares after option exercise | EYPT Insider Trading - Stock Titan
Spruce Street Capital LP's EyePoint Inc(EYPT) Holding History - GuruFocus
EYPT Rated Buy by Chardan Capital -- Price Target Raised to $65. - GuruFocus
Did Broad Russell Growth Index Additions Just Reframe EyePoint’s (EYPT) Small-Cap Biotech Profile? - Sahm
Chardan Boosts Price Target on EyePoint Pharmaceuticals to $65 From $29, Keeps Buy Rating - marketscreener.com
Huge - Moomoo
Chardan Capital Maintains EyePoint(EYPT.US) With Buy Rating, Raises Target Price to $65 - Moomoo
EyePoint, Inc.(NasdaqGM: EYPT) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
EyePoint, Inc.(NasdaqGM: EYPT) added to Russell 2500 Growth Benchmark - marketscreener.com
Pivotal Clinical Trial Readouts On The Horizon; Keeping An Eye On EyePoint? - RTTNews
EyePoint, Inc.(NasdaqGM: EYPT) added to Russell 2000 Growth Benchmark - marketscreener.com
EyePoint, Inc.(NasdaqGM: EYPT) added to Russell 3000E Growth Benchmark - marketscreener.com
EyePoint, Inc.(NasdaqGM: EYPT) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Enterprise value to EBITDA forward of EyePoint, Inc. – NASDAQ:EYPT - TradingView
EyePoint, Inc. Actuals & Estimates (NASDAQ:EYPT) - TradingView
Price to book forward of EyePoint, Inc. – NASDAQ:EYPT - TradingView
Price to book forward of EyePoint, Inc. – LS:A2QJRU - TradingView
EYPT Forecast — Price Target — Prediction for 2027 - TradingView
EyePoint, Inc. Actuals & Estimates (DUS:PV3B) - TradingView
EYPT Q1 2026 Earnings: Wider-than-Expected Loss as Clinical Expenses MountEPS Consistency Score - dars.gov.et
(EYPT) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Price to sales forward of EyePoint, Inc. – LS:A2QJRU - TradingView
EyePoint Inc (EYPT) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Enterprise value to revenue forward of EyePoint, Inc. – NASDAQ:EYPT - TradingView
Price to earnings forward of EyePoint, Inc. – LS:A2QJRU - TradingView
A2QJRU Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to revenue forward of EyePoint, Inc. – LS:A2QJRU - TradingView
EyePoint Pharmaceuticals Inc (EYPT) Institutional Confidence - TradingKey
Guggenheim Maintains EyePoint(EYPT.US) With Buy Rating, Maintains Target Price $68 - Moomoo
EYPT Reiterated by Guggenheim -- Price Target Maintained at $68. - GuruFocus
Mizuho reiterates EyePoint stock rating on competitor timeline shift By Investing.com - Investing.com South Africa
Mizuho reiterates EyePoint stock rating on competitor timeline shift - Investing.com
Mizuho Securities Maintains EyePoint(EYPT.US) With Buy Rating, Maintains Target Price $36 - Moomoo
EyePoint stockholders approve incentive plan amendment and elect directors By Investing.com - Investing.com South Africa
EyePoint, Inc. Approves Executive Compensation and Amends 2023 Long-Term Incentive Plan in Latest 8-K Filing - Minichart
Form 8K Eyepoint Pharmaceuticals Inc For: 22 June By Investing.com - Investing.com Nigeria
EyePoint stockholders approve incentive plan amendment and elect directors - Investing.com
EyePoint (EYPT) investors approve 4.9M-share incentive plan increase and all 2026 AGM proposals - Stock Titan
EyePoint Pharmaceuticals Inc (EYPT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
symbol__ Stock Quote Price and Forecast - CNN
JonesTrading Maintains EyePoint(EYPT.US) With Buy Rating, Maintains Target Price $43 - Moomoo
EyePoint Pharmaceuticals Inc - TradingKey
EyePoint Pharmaceuticals Inc (EYPT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
EyePoint Pharmaceuticals Inc (EYPT) Valuation: PE, PB & Fair Value Analysis - TradingKey
EyePoint Pharmaceuticals Inc (EYPT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
EyePoint Pharmaceuticals Inc (EYPT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
EyePoint Pharmaceuticals Inc (EYPT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - The Manila Times
(EYPT) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
1.21%
3.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):